PBLS

31.20

3.91% -1.27

Handel nachbörslich: 31.20

Parabilis Medicines Inc (PBLS)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$32.47

Offen:

$32.32

24-Stunden-Volumen:

1.12M

Relative Volume:

1.74

Marktkapitalisierung:

$3.85B

Einnahmen:

Nettoeinkommen (Verlust:

KGV:

EPS:

Netto-Cashflow:

1W Leistung:

-25.23%

1M Leistung:

-20.47%

6M Leistung:

+0.00%

1J Leistung:

+0.00%

1-Tages-Spanne:

$29.57

$32.32

1-Wochen-Bereich:

$29.57

$42.31

52-Wochen-Spanne:

$24.51

$42.48

Parabilis Medicines Inc Stock (PBLS) Company Profile

Firmenname

Parabilis Medicines Inc

Sektor

Healthcare (1067)

Branche

Biotechnology (595)

Telefon

Adresse

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-11-12

Neueste SEC-Einreichungen

PBLS's Discussions on Twitter

Compare PBLS vs VRTX, REGN, MRNA, ARGX, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PBLS Parabilis Medicines Inc	31.20	3.85B	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	526.19	133.37B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	788.04	81.13B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	198.88	79.40B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	959.49	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	204.97	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Parabilis Medicines Inc Aktie (PBLS) Neueste Nachrichten

Sep 21, 2026

PBLS Price Today: Parabilis Medicines, Inc. Stock Price, Quote & Chart | MEXC - mexc.co

Sep 21, 2026

Top Parabilis Medicines (PBLS) Competitors 2026 - MarketBeat

Sep 21, 2026

Parabilis Medicines (NASDAQ:PBLS) Stock Price Down 6.3%What's Next? - MarketBeat

Sep 21, 2026

Sep 20, 2026

Parabilis Medicines, Inc.(NasdaqGS: PBLS) added to S&P TMI Index - marketscreener.com

Sep 20, 2026

Parabilis Medicines, Inc. (NASDAQ:PBLS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Sep 20, 2026

Sep 18, 2026

Biotech Stocks At 52-Week HighsMNOV +36%, PBLS +10%, ABCL +9%, HAE, NEO - RTTNews

Sep 18, 2026

Sep 17, 2026

Parabilis Medicines, Inc.(NasdaqGS: PBLS) added to Russell 3000 Growth Index - marketscreener.com

Sep 17, 2026

Parabilis Medicines (NASDAQ:PBLS) Hits New 52-Week HighTime to Buy? - MarketBeat

Sep 17, 2026

BofA Securities Maintains Parabilis Medicines(PBLS.US) With Buy Rating, Announces Target Price $45 - Moomoo

Sep 17, 2026

48,484 Shares in Parabilis Medicines, Inc. $PBLS Acquired by Squarepoint Ops LLC - MarketBeat

Sep 17, 2026

Sep 16, 2026

PBLS: Zolucatetide advances as a multi-indication therapy, with strong data and broad pipeline expansion - TradingView

Sep 16, 2026

Parabilis at Morgan Stanley conference: broad bet on beta-catenin - Investing.com

Sep 16, 2026

PBLS: Zolucatetide's clinical progress and platform innovation drive a broad pipeline and major upcoming milestones - TradingView

Sep 16, 2026

Parabilis Medicines (NASDAQ:PBLS) Trading Up 6%Still a Buy? - MarketBeat

Sep 16, 2026

Sep 15, 2026

Parabilis Medicines to Showcase Updated Zolucatetide Trial Results at ESMO 2026 - Kalkine Media

Sep 15, 2026

Sep 14, 2026

WINTON GROUP Ltd Takes Position in Parabilis Medicines, Inc. $PBLS - marketbeat.com

Sep 14, 2026

Sep 11, 2026

Parabilis Medicines (PBLS) Short Interest & Short Float | Updated Sep 2026 - MarketBeat

Sep 11, 2026

Sep 07, 2026

1,920,805 Shares in Parabilis Medicines, Inc. $PBLS Purchased by Frazier Life Sciences Management L.P. - MarketBeat

Sep 07, 2026

Sep 04, 2026

Parabilis Medicines, Inc. Common Stock (NASDAQ: PBLS) Stock Price, News & Analysis - Kalkine

Sep 04, 2026

Sep 01, 2026

Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewswire

Sep 01, 2026

Aug 31, 2026

ICONIQ Capital LLC Takes $9.58 Million Position in Parabilis Medicines, Inc. $PBLS - MarketBeat

Aug 31, 2026

Aug 29, 2026

Regeneron Pharmaceuticals Inc. Buys New Stake in Parabilis Medicines, Inc. $PBLS - MarketBeat

Aug 29, 2026

Aug 28, 2026

1,600,937 Shares in Parabilis Medicines, Inc. $PBLS Purchased by General Catalyst Group Management LLC - MarketBeat

Aug 28, 2026

venBio Partners LLC Takes $144.15 Million Position in Parabilis Medicines, Inc. $PBLS - MarketBeat

Aug 28, 2026

Jupiter Topco LLC Buys Shares of 2,296,547 Parabilis Medicines, Inc. $PBLS - MarketBeat

Aug 28, 2026

Aug 26, 2026

Parabilis Medicines, Inc. (NASDAQ:PBLS) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Aug 26, 2026

Aug 25, 2026

Parabilis appoints Craig Tendler to its Board and Science & Technology Committee - TradingView

Aug 25, 2026

Parabilis Medicines adds former J&J oncology executive to board By Investing.com - Investing.com Canada

Aug 25, 2026

Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors - finance.yahoo.com

Aug 25, 2026

Aug 24, 2026

ICONIQ Capital LLC Makes New Investment in Parabilis Medicines, Inc. $PBLS - MarketBeat

Aug 24, 2026

Aug 19, 2026

Parabilis Medicines Price Insights - YCharts

Aug 19, 2026

Aug 18, 2026

Parabilis Medicines (NASDAQ:PBLS) Stock Price Up 5.9%Here's What Happened - MarketBeat

Aug 18, 2026

Alphabet Inc. Makes New $134.65 Million Investment in Parabilis Medicines, Inc. $PBLS - MarketBeat

Aug 18, 2026

Aug 17, 2026

Focus Partners Advisor Solutions LLC Invests $1.35 Million in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 17, 2026

Aug 15, 2026

Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Celcuity (CELC) and Parabilis Medicines, Inc. (PBLS) - The Globe and Mail

Aug 15, 2026

Aug 14, 2026

Parabilis Medicines(PBLS) Stock Options Chain | Quotes & News - Moomoo

Aug 14, 2026